Equity Profile

BAX

Baxter International Inc.

Health CareHealth Care Equipment$14.0B

Jul30Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Baxter International Inc. is a healthcare company that specializes in medical devices and equipment....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and performance, which investors closely monitor.

$0.54

Revenue

Total revenue provides insight into the company's sales performance and market demand for its products.

$2.9B

Wall Street expectations, options signals, track record, and call prep available with Pro.

BAX Q2-2026 Earnings Preview

Context

Company Snapshot

Baxter International Inc. is a healthcare company that specializes in medical devices and equipment. With a market cap of $14 billion, it plays a crucial role in providing essential products for patients and healthcare providers, particularly in areas like fluid management and renal care.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+5.06%

Avg Stock Reaction

-4.92%

Last Quarter Recap

In Q1 2026, Baxter reported an EPS of $0.36, beating estimates by 15.38%. The stock reacted positively, gaining 4.02% the next day.

Management Promises & Guidance

Continued focus on innovation in medical devices.
Commitment to improving operational efficiencies.
Plans to expand into emerging markets.

Expectations

Wall Street Expectations

Analysts expect Baxter to report steady earnings and revenue growth, reflecting ongoing demand for its healthcare products.

Bull Case

If Baxter exceeds EPS and revenue expectations, it could signal strong operational performance and increased market confidence.

Bear Case

A miss on earnings or revenue could raise concerns about market demand and operational challenges, leading to negative investor sentiment.

Key Metrics to Watch

EPS

$0.54

Earnings per share is a key indicator of profitability and performance, which investors closely monitor.

Revenue

$2.9B

Total revenue provides insight into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Baxter achieve an EPS of $0.54 or higher?

This figure is critical as it reflects the company's profitability and can significantly influence stock performance.

How does Baxter's revenue compare to the $2.9B consensus?

Revenue performance will indicate market demand and the effectiveness of Baxter's sales strategies.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Baxter's ability to leverage its recent innovations in medical devices, which could drive higher-than-expected demand.

Supporting Evidence

Baxter's recent product launches have received positive feedback from healthcare providers.

The company's strong operational improvements may not be fully reflected in current estimates.

Options pricing suggests a lower expected move than historical averages, indicating potential undervaluation.

Key Risk

If revenue comes in below $2.8B, it could undermine confidence in the company's growth prospects.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's results will be closely watched as they could indicate the company's ability to navigate market challenges.

Bull Confirmed If

An EPS of $0.54 or better with revenue exceeding $2.9B would confirm strong operational performance.

Bear Confirmed If

An EPS below $0.50 or revenue below $2.8B would raise concerns about demand and execution.

Pre-Earnings Positioning

Options Market

Implied Move

±6.74%

Historical Avg

±9.7%

Pricing cheap

The options market is pricing in a moderate move around the earnings report, suggesting uncertainty about the results.

Options are pricing ±6.7% while BAX has averaged ±9.7% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.5%

30d HV

40.0%

Calls (51K)P/C Ratio: 0.52Puts (20K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options pricing cheap in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Baxter beats expectations, history suggests the stock could rise by about 0.59% on the following day, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may see a muted reaction as investors await further guidance.

Miss

A miss on earnings could lead to a decline of around 14.10%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on new product launches and their market reception.
2Any commentary on operational efficiencies and cost management.
3Insights into market demand trends for healthcare equipment.
4Management's outlook on emerging market expansion.
5Responses to competitive pressures in the healthcare sector.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

DYNBMO

Dyne Therapeutics, Inc.

PreviewView

Jul27

ARLPBMO

Company Snapshot

Baxter International Inc. is a healthcare company that specializes in medical devices and equipment....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and performance, which investors closely monitor.

$0.54

Revenue

Total revenue provides insight into the company's sales performance and market demand for its products.

$2.9B

Wall Street expectations, options signals, track record, and call prep available with Pro.

BAX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

63%

Avg EPS Surprise

+5.06%

Avg Stock Reaction

-4.92%

Last Quarter Recap

In Q1 2026, Baxter reported an EPS of $0.36, beating estimates by 15.38%. The stock reacted positively, gaining 4.02% the next day.

Management Promises & Guidance

Continued focus on innovation in medical devices.
Commitment to improving operational efficiencies.
Plans to expand into emerging markets.

Expectations

Wall Street Expectations

Analysts expect Baxter to report steady earnings and revenue growth, reflecting ongoing demand for its healthcare products.

Bull Case

If Baxter exceeds EPS and revenue expectations, it could signal strong operational performance and increased market confidence.

Bear Case

A miss on earnings or revenue could raise concerns about market demand and operational challenges, leading to negative investor sentiment.

Key Metrics to Watch

EPS

$0.54

Earnings per share is a key indicator of profitability and performance, which investors closely monitor.

Revenue

$2.9B

Total revenue provides insight into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Baxter achieve an EPS of $0.54 or higher?

This figure is critical as it reflects the company's profitability and can significantly influence stock performance.

How does Baxter's revenue compare to the $2.9B consensus?

Revenue performance will indicate market demand and the effectiveness of Baxter's sales strategies.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Baxter's ability to leverage its recent innovations in medical devices, which could drive higher-than-expected demand.

Supporting Evidence

Baxter's recent product launches have received positive feedback from healthcare providers.

The company's strong operational improvements may not be fully reflected in current estimates.

Options pricing suggests a lower expected move than historical averages, indicating potential undervaluation.

Key Risk

If revenue comes in below $2.8B, it could undermine confidence in the company's growth prospects.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's results will be closely watched as they could indicate the company's ability to navigate market challenges.

Bull Confirmed If

An EPS of $0.54 or better with revenue exceeding $2.9B would confirm strong operational performance.

Bear Confirmed If

An EPS below $0.50 or revenue below $2.8B would raise concerns about demand and execution.

Pre-Earnings Positioning

Options Market

Implied Move

±6.74%

Historical Avg

±9.7%

Pricing cheap

The options market is pricing in a moderate move around the earnings report, suggesting uncertainty about the results.

Options are pricing ±6.7% while BAX has averaged ±9.7% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.5%

30d HV

40.0%

Calls (51K)P/C Ratio: 0.52Puts (20K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options pricing cheap in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Baxter beats expectations, history suggests the stock could rise by about 0.59% on the following day, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may see a muted reaction as investors await further guidance.

Miss

A miss on earnings could lead to a decline of around 14.10%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on new product launches and their market reception.
2Any commentary on operational efficiencies and cost management.
3Insights into market demand trends for healthcare equipment.
4Management's outlook on emerging market expansion.
5Responses to competitive pressures in the healthcare sector.